Literature DB >> 16844227

Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome.

Sophia Dona Koukoui1, Avi Chaudhuri.   

Abstract

Fragile X syndrome (FXS) is a leading cause of inherited mental retardation. In the vast majority of cases, this X-linked disorder is due to a CGG expansion in the 5' untranslated region of the fmr-1 gene and the resulting decreased expression of its associated protein, FMRP. FXS is characterized by a number of cognitive, behavioral, anatomical, and biological abnormalities. FXS provides a unique opportunity to study the consequence of mutation in a single gene on the development and proper functioning of the CNS. The current focus on the role of FMRP in neuronal maturation makes it timely to assemble the extant information on how reduced expression of the fmr-1 gene leads to neuronal dysmorphology. The purpose of this review is to summarize recent genetic, neuroanatomical, and behavioral studies of fragile X syndrome and to offer potential mechanisms to account for the pleiotropic phenotype of this disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844227     DOI: 10.1016/j.brainresrev.2006.06.001

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  28 in total

Review 1.  Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome.

Authors:  E Walter; P K Mazaika; A L Reiss
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

Review 2.  Fragile X-associated disorders: a clinical overview.

Authors:  Anne Gallagher; Brian Hallahan
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

3.  GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.

Authors:  Marjelo A Mines; Christopher J Yuskaitis; Margaret K King; Eleonore Beurel; Richard S Jope
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

Review 4.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

5.  The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome.

Authors:  Samantha Portis; Brian Giunta; Demian Obregon; Jun Tan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

Review 6.  Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.

Authors:  Clare M Gladding; Stephen M Fitzjohn; Elek Molnár
Journal:  Pharmacol Rev       Date:  2009-11-19       Impact factor: 25.468

7.  Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Development       Date:  2008-06-25       Impact factor: 6.868

Review 8.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

9.  Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice.

Authors:  Yair Pilpel; Aleksander Kolleker; Sven Berberich; Melanie Ginger; Andreas Frick; Edwin Mientjes; Ben A Oostra; Peter H Seeburg
Journal:  J Physiol       Date:  2008-12-22       Impact factor: 5.182

10.  Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses.

Authors:  Willem Ma Verhoeven; Siegfried Tuinier; Ineke van der Burgt
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.